Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: An updated meta-analysis of six randomized controlled trials

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 4, 2014, Pages 354-360

  Xu, Jun ^a   Ma, Rui ^a   Chen, Li Feng ^a   Zhao, Li Jun ^a   Chen, Kan ^a   Zhang, Ren Bing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

ammonia; hepatic encephalopathy; liver cirrhosis; meta analysis; probiotics

Indexed keywords

AMMONIA; PROBIOTIC AGENT;

AMMONIA BLOOD LEVEL; ARTICLE; COCHRANE LIBRARY; COLONY FORMING UNIT; CONSTIPATION; EMBASE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MEDLINE; META ANALYSIS; MORTALITY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); INTESTINE; MICROBIOLOGY; RISK; TREATMENT OUTCOME;

HEPATIC ENCEPHALOPATHY; HUMANS; INTESTINES; LIVER CIRRHOSIS; ODDS RATIO; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84913593061     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60280-0     Document Type: Article

References (31)

1. P Ferenci, A Lockwood, K Mullen, R Tarter, K Weissenborn, AT Blei Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 Hepatology 35 2002 716 721
2. Y Eroglu, WJ Byrne Hepatic encephalopathy Emerg Med Clin North Am 27 2009 401 414
3. FF Poordad Review article: the burden of hepatic encephalopathy Aliment Pharmacol Ther 25 2007 3 9
4. G D'Amico, G Garcia-Tsao, L Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
5. RS Rahimi, DC Rockey Complications of cirrhosis Curr Opin Gastroenterol 28 2012 223 229
6. A Gupta, RK Dhiman, S Kumari, S Rana, R Agarwal, A Duseja et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy J Hepatol 53 2010 849 855
7. C Pande, A Kumar, SK Sarin Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease Aliment Pharmacol Ther 29 2009 1273 1281
8. TM Bauer, H Schwacha, B Steinbrückner, FE Brinkmann, AK Ditzen, JJ Aponte et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia Am J Gastroenterol 97 2002 2364 2370
9. SF Solga Probiotics can treat hepatic encephalopathy Med Hypotheses 61 2003 307 313
10. G Wright, A Chattree, R Jalan Management of hepatic encephalopathy Int J Hepatol 2011 2011 841407
11. K Holte, A Krag, LL Gluud Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy Hepatol Res 42 2012 1008 1015
12. RG McGee, A Bakens, K Wiley, SM Riordan, AC Webster Probiotics for patients with hepatic encephalopathy Cochrane Database Syst Rev 9 2012 CD008716.
13. MK Lunia, BC Sharma, P Sharma, S Sachdeva, S Srivastava Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial Clin Gastroenterol Hepatol 12 2014 1003 1008
14. A Agrawal, BC Sharma, P Sharma, SK Sarin Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy Am J Gastroenterol 107 2012 1043 1050
15. S Saji, S Kumar, V Thomas A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy Trop Gastroenterol 32 2011 128 132
16. D Pereg, A Kotliroff, N Gadoth, R Hadary, M Lishner, Y Kitay-Cohen Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study Nutrition 27 2011 177 181
17. AR Jadad, RA Moore, D Carroll, C Jenkinson, DJ Reynolds, DJ Gavaghan et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
18. SA Olivo, LG Macedo, IC Gadotti, J Fuentes, T Stanton, DJ Magee Scales to assess the quality of randomized controlled trials: a systematic review Phys Ther 88 2008 156 175
19. VV Mittal, BC Sharma, P Sharma, SK Sarin A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy Eur J Gastroenterol Hepatol 23 2011 725 732
20. JS Bajaj, K Saeian, KM Christensen, M Hafeezullah, RR Varma, J Franco et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy Am J Gastroenterol 103 2008 1707 1715
21. P Amodio, F Del Piccolo, E Pettenò, D Mapelli, P Angeli, R Iemmolo et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients J Hepatol 35 2001 37 45
22. N Saxena, M Bhatia, YK Joshi, PK Garg, SN Dwivedi, RK Tandon Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy Liver 22 2002 190 197
23. GV Papatheodoridis, J Goulis, G Leandro, D Patch, AK Burroughs Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis Hepatology 30 1999 612 622
24. W Nolte, J Wiltfang, C Schindler, H Münke, K Unterberg, U Zumhasch et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations Hepatology 28 1998 1215 1225
25. IJ Hartmann, M Groeneweg, JC Quero, SJ Beijeman, RA de Man, WC Hop et al. The prognostic significance of subclinical hepatic encephalopathy Am J Gastroenterol 95 2000 2029 2034
26. M Ortiz, C Jacas, J Córdoba Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations J Hepatol 42 2005 S45 S53
27. SL Gorbach Probiotics and gastrointestinal health Am J Gastroenterol 95 2000 S2 S4
28. Q Liu, ZP Duan, DK Ha, S Bengmark, J Kurtovic, SM Riordan Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 2004 1441 1449
29. M Malaguarnera, F Greco, G Barone, MP Gargante, M Malaguarnera, MA Toscano Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study Dig Dis Sci 52 2007 3259 3265
30. J Lata, J Jurankova, M Kopacova, P Vitek Probiotics in hepatology World J Gastroenterol 17 2011 2890 2896
31. P Sharma, BC Sharma, V Puri, SK Sarin An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy Eur J Gastroenterol Hepatol 20 2008 506 511